TEST KIT, HUMAN IMMUNODEFICIENCY VIRUS DE

The contract specifies the procurement of Human Immunodeficiency Virus (HIV) Detection Test Kits, designed to identify HIV-1 and HIV-2 antigens and antibodies in whole blood samples. Each package contains five test cards with five tests per card, totaling 25 tests per package, along with a desiccant pack, a 2.5 mL chase buffer in phosphate solution, a quick reference guide, a package insert, 25 disposable capillary tubes, 25 disposable workstations, 25 subject information notices, and a customer letter. The unit of issue is PG, with each package containing 25 tests. The kits must meet strict technical and quality standards referenced in the DLA Master List of Technical and Quality Requirements, and applicable packaging requirements as defined by DLA packaging standards. The items must be packaged commercially in sealed containers that protect against damage and meet the Medical Marking Standard No. 1, replacing all prior MIL-STD-129 references. The test kits have a non-extendable shelf life of 18 months, with no more than two months having elapsed from the date of manufacture to the date of delivery to the government. Labeling must include the date of manufacture, expiration date, contract number, and lot number, in compliance with the latest revision of MMS1C. The item is identified by NSN 6550-01-692-1809, with a procurement quantity of 3 packages, and a delivery requirement within 83 days of award. The solicitation is issued under SPE2DS-26-T-289S, with a response deadline of August 5, 2026, and is managed by the Department of Defense’s Medical Supply Chain organization. The place of performance is APO, with primary point of contact provided for contractual inquiries. Covered defense information may apply, and removal of government identification from non-accepted supplies is required.